Clinical Trials Browser

Phase 2/3 × pirarubicin × Gastrointestinal × Clear all

NCT02585479 2019-06-04

Systemic Chemotherapy Versus Transcatheter Arterial Chemoembolization(TACE) for Hepatocellular Carcinoma

Phase 2/3 Withdrawn

Gastrointestinal

Carcinoma, Hepatocellular